Patent application number | Description | Published |
20080248591 | Gas bubble biosensor - The present invention describes a biosening device and method. Specifically, binding of target analyte perturbs the surface of a sensor strip so that gas bubbles are generated in solution. Said gas bubbles may be detected for determination of analyte presence in sample. | 10-09-2008 |
20090020541 | Self-cooling plastic drink bottle - The present invention describes an improved plastic drink bottle. By preparing a drink bottle with separate closed internal compartments that allow for access to drinking fluids in one or both closed internal compartments, one may effectively cool beverages and supply more than one beverage in a single drink bottle. | 01-22-2009 |
20090134986 | In-transitcar alarm - The present invention describes a car anti-theft system. Specifically, the present invention has an organic light-emitting diode (OLED) patterned onto a visible surface of a vehicle. Vehicle theft is recognized when an unauthorized driver fails to enter a predetermined code, resulting in lighting of OLED. Lighted OLED may be seen by passers-by who may then alert police that a car is in the process of being stolen. Alternatively and additionally, OLED's may be integrated into primary car alarm systems so as to add an additional, visual, layer of car protection. | 05-28-2009 |
20090155864 | SYSTEMS, METHODS, AND DEVICES FOR EMPLOYING SOLAR ENERGY TO PRODUCE BIOFUELS - A photo-bioreactor can be arranged to receive incident solar radiation. The photo-bioreactor can contain photosynthetic organisms. The photosynthetic organisms can be genetically modified to produce an organic substance. The organic substance can be a biofuel or a precursor to a biofuel. The precursor can be isolated and converted into a biofuel. The biofuel can be extracted from the photo-bioreactor for use, for example, in energy generation or as a fuel. | 06-18-2009 |
20090186421 | Catalytic Biosensor - The present invention describes a biosening device and method. Specifically, binding of target analyte perturbs the surface of a sensor strip so that gas bubbles are generated in solution. The gas bubbles may be detected for determination of analyte presence in a sample. | 07-23-2009 |
20130168266 | METHODS AND DEVICES FOR INDENTIFYING AN ANALYTE - The present invention describes a biosensing device and method. Specifically, binding of target analyte to a sensor strip provides for reduction of metal ions in solution. The reduced metal can perform catalytic reactions leading to the production of easily identifiable products such as gas bubbles or colored molecules. | 07-04-2013 |
20150053577 | DEVICES AND METHODS FOR IDENTIFYING A BIOLOGICAL OR CHEMICAL RESIDUE IN AN AQUEOUS SAMPLE - The invention discloses methods and devices for rapidly detecting a biological or other residue in a liquid sample. In some embodiments of the instant invention, a single electrode is employed to contact a flowing aqueous solution, with electrical outputs being recorded by an electrical metering device. Injection or flow of sample leads to changes in solution electrostatic behavior; those changes are recorded in the metering device, with absence of predetermined residues or targets yielding the highest signals. General and specific target detection may be performed with various embodiments of the instant invention. | 02-26-2015 |
Patent application number | Description | Published |
20090131305 | ALPHA-1 ANTITRYPSIN FOR TREATING EXACERBATION EPISODES OF PULMONARY DISEASES - The present invention relates to methods for the treatment of exacerbation periods of pulmonary diseases, particularly chronic obstructive pulmonary diseases, by administering alpha-1 antitrypsin (AAT) to a subject in need thereof. Particularly, the present invention discloses the efficient treatment of exacerbation periods of pulmonary diseases by administering AAT via inhalation. | 05-21-2009 |
20090304604 | PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR - The present invention relates to a system that includes a pharmaceutical composition of a purified, stable, active alpha-1 proteinase inhibitor (API) in a form of a ready to use sterile solution and an inhalation nebulizer, and to methods of use thereof for treating pulmonary diseases. | 12-10-2009 |
20110092444 | LARGE SCALE PREPARATION OF ALPHA-1 PROTEINASE INHIBITOR AND USE THEREOF - A pharmaceutical preparation containing a purified, active API in the form of a ready to use sterile solution that optionally includes an excipient, diluent or a carrier. At least 90% to 95% of the API is active and is present at a concentration between about 1% to about 10%. The pH of the preparation is in the range of 6.5-7.5 and the preparation is preferably devoid of a protein stabilizer. The API is stable for at least 3 months when stored at a temperature of between 20° C. to 25° C. and is stable for a minimum of at least 12 months, at least 21 months, or at least 36 months when the pharmaceutical composition is stored at a temperature of between 2° C. to 8° C. The composition is formulated to be administered intravenously or by inhalation. | 04-21-2011 |
20120211005 | PULMONARY DELIVERY OF ALPHA-1 PROTEINASE INHIBITOR - The present invention relates to a system that includes a pharmaceutical composition of a purified, stable, active alpha-1 proteinase inhibitor (API) in a form of a ready to use sterile solution and an inhalation nebulizer, and to methods of use thereof for treating pulmonary diseases. | 08-23-2012 |